Literature DB >> 24518621

Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.

Zhabiz Golkar1, Omar Bagasra, Donald Gene Pace.   

Abstract

The emergence of multiple drug-resistant bacteria has prompted interest in alternatives to conventional antimicrobials. One of the possible replacement options for antibiotics is the use of bacteriophages as antimicrobial agents. Phage therapy is an important alternative to antibiotics in the current era of drug-resistant pathogens. Bacteriophages have played an important role in the expansion of molecular biology and have been used as antibacterial agents since 1966. In this review, we describe a brief history of bacteriophages and clinical studies on their use in bacterial disease prophylaxis and therapy. We discuss the advantages and disadvantages of bacteriophages as therapeutic agents in this regard.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24518621     DOI: 10.3855/jidc.3573

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  111 in total

1.  The antibiotic resistance crisis: part 2: management strategies and new agents.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-05

2.  The antibiotic resistance crisis: part 1: causes and threats.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-04

Review 3.  Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens.

Authors:  Ramesh Subramani; Mathivanan Narayanasamy; Klaus-D Feussner
Journal:  3 Biotech       Date:  2017-06-29       Impact factor: 2.406

Review 4.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.

Authors:  Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

Review 5.  Veterinary pharmaceuticals in aqueous systems and associated effects: an update.

Authors:  Samuel Obimakinde; Olalekan Fatoki; Beatrice Opeolu; Olatunde Olatunji
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-18       Impact factor: 4.223

6.  Influence of some environmental variables and addition of r-lysozyme on efficacy of Vibrio harveyi phage for therapy.

Authors:  Tanmoy Gon Choudhury; Biswajit Maiti; M N Venugopal; Indrani Karunasagar
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

7.  Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus.

Authors:  Ara Jo; Tian Ding; Juhee Ahn
Journal:  Food Sci Biotechnol       Date:  2016-06-30       Impact factor: 2.391

8.  A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.

Authors:  Jieun Kwon; Tina Mistry; Jinhong Ren; Michael E Johnson; Shahila Mehboob
Journal:  Bioorg Med Chem       Date:  2017-11-11       Impact factor: 3.641

Review 9.  Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria.

Authors:  Neelam Taneja; Harsimran Kaur
Journal:  Microbiol Insights       Date:  2016-03-20

10.  Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics.

Authors:  Tucker Maxson; Douglas A Mitchell
Journal:  Tetrahedron       Date:  2015-10-09       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.